PuSH - Publication Server of Helmholtz Zentrum München

32 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
21.
Finan, B. et al.: Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic Impact for metabolic disease. Cell 167, 843-857.e14 (2016)
22.
Kabra, D.G. et al.: Hypothalamic leptin action is mediated by histone deacetylase 5. Nat. Commun. 7:10782 (2016)
23.
Quarta, C. ; Sánchez-Garrido, M.A. ; Tschöp, M.H. & Clemmensen, C.: Renaissance of leptin for obesity therapy. Diabetologia 59, 920-927 (2016)
24.
Quarta, C. & Clemmensen, C.: Unforeseen role for glucocorticoids in combinatorial anti-obesity pharmacology. Mol. Metab. 5, 435-436 (2016)
25.
Sánchez-Garrido, M.A. et al.: Fibroblast activation protein (FAP) as a novel metabolic target. Mol. Metab. 5, 1015-24 (2016)
26.
Tschöp, M.H. et al.: Unimolecular polypharmacy for treatment of diabetes and obesity. Cell Metab. 24, 51-62 (2016)
27.
Clemmensen, C. et al.: Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice. EMBO Mol. Med. 7, 288-298 (2015)
28.
Finan, B. et al.: A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. J. Nat. Med. 21, 27-36 (2015)
29.
Finan, B. ; Clemmensen, C. & Müller, T.D.: Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists. Mol. Cell. Endocrinol. 418, 42-54 (2015)
30.
Fischer, K. et al.: The pentapeptide RM-131 promotes food intake and adiposity in wildtype mice but not in mice lacking the ghrelin receptor. Front. Nutr. 1:31 (2015)
31.
Müller, T.D. ; Clemmensen, C. ; Finan, B. ; DiMarchi, R.D.* & Tschöp, M.H.: Novel combinatorial therapies involving leptin: Opportunities for mechanistic advances and therapeutic translation in human diseases, In: Dagogo-Jack, S.* [Eds.]: Leptin : Regulation and Clinical Applications. 2015. 267-279
32.
Clemmensen, C. et al.: GLP-1/glucagon co-agonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63, 1422-1427 (2014)